APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccine Against Infectious Coryza for Poultry

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Vaccine Against Infectious Coryza for Poultry Industry Growth and Trends Forecast to 2032

22 December 202595 pages

Choose your research edition.

Industry ResearchVaccine Against Infectious Coryza for Poultry Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine Against Infectious Coryza for Poultry Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Vaccine Against Infectious Coryza for Poultry Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine Against Infectious Coryza for Poultry Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccine Against Infectious Coryza for Poultry Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Vaccine Against Infectious Coryza for Poultry market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vaccine Against Infectious Coryza for Poultry is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vaccine Against Infectious Coryza for Poultry is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaccine Against Infectious Coryza for Poultry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vaccine Against Infectious Coryza for Poultry include HIPRA, MSD Animal Health, Qilu Animal Health, Ringpu, Shandong Huahong Biological, Shandong Lvdu Bio-Sciences, Wohua Biotech and Jilin Zhengye Biological Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vaccine Against Infectious Coryza for Poultry market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vaccine Against Infectious Coryza for Poultry market size, estimates, and forecasts are presented in terms of sales volume (k doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vaccine Against Infectious Coryza for Poultry market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vaccine Against Infectious Coryza for Poultry.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Vaccine Against Infectious Coryza for Poultry market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vaccine Against Infectious Coryza for Poultry Market by Company

HIPRA

MSD Animal Health

Qilu Animal Health

Ringpu

Shandong Huahong Biological

Shandong Lvdu Bio-Sciences

Wohua Biotech

Jilin Zhengye Biological Products

Vaccine Against Infectious Coryza for Poultry Segment by Type

Serotype A

Serotype A + Serotype B

Serotype A + Serotype B + Serotype C

Vaccine Against Infectious Coryza for Poultry Segment by Application

Government Tender

Market Sales

Vaccine Against Infectious Coryza for Poultry Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Against Infectious Coryza for Poultry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine Against Infectious Coryza for Poultry and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Against Infectious Coryza for Poultry.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vaccine Against Infectious Coryza for Poultry manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Vaccine Against Infectious Coryza for Poultry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Serotype A Table 2. Major Company of Serotype A + Serotype B Table 3. Major Company of Serotype A + Serotype B + Serotype C Table 4. Global Vaccine Against Infectious Coryza for Poultry Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2026) & (k doses) Table 6. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Type (2021-2026) Table 7. Global Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2026) & (US$ Million) Table 8. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Type (2021-2026) Table 9. Global Vaccine Against Infectious Coryza for Poultry Price by Type (2021-2026) & (US$/k dose) Table 10. Global Vaccine Against Infectious Coryza for Poultry Sales by Type (2027-2032) & (k doses) Table 11. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Type (2027-2032) Table 12. Global Vaccine Against Infectious Coryza for Poultry Sales by Type (2027-2032) & (US$ Million) Table 13. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Type (2027-2032) Table 14. Global Vaccine Against Infectious Coryza for Poultry Price by Type (2027-2032) & (US$/k dose) Table 15. North America Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2026) & (k doses) Table 16. North America Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2026) & (k doses) Table 18. Europe Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2026) & (k doses) Table 20. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2026) & (k doses) Table 22. Latin America Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2026) & (k doses) Table 24. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2026) & (US$ Million) Table 25. Vaccine Against Infectious Coryza for Poultry Industry Trends Table 26. Vaccine Against Infectious Coryza for Poultry Industry Drivers Table 27. Vaccine Against Infectious Coryza for Poultry Industry Opportunities and Challenges Table 28. Vaccine Against Infectious Coryza for Poultry Industry Restraints Table 29. Global Vaccine Against Infectious Coryza for Poultry Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Company (2021-2026) Table 31. Global Vaccine Against Infectious Coryza for Poultry Sales by Company (2021-2026) & (k doses) Table 32. Global Vaccine Against Infectious Coryza for Poultry Sales Share by Company (2021-2026) Table 33. Global Vaccine Against Infectious Coryza for Poultry Market Price by Company (2021-2026) & (US$/k dose) Table 34. Global Vaccine Against Infectious Coryza for Poultry Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Vaccine Against Infectious Coryza for Poultry Major Company Production Sites and Headquarters Table 36. Global Vaccine Against Infectious Coryza for Poultry Company, Product Type & Application Table 37. Global Vaccine Against Infectious Coryza for Poultry Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Vaccine Against Infectious Coryza for Poultry by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Vaccine Against Infectious Coryza for Poultry Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Vaccine Against Infectious Coryza for Poultry Sales by Region (2021-2026) & (k doses) Table 42. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Region (2021-2026) Table 43. Global Vaccine Against Infectious Coryza for Poultry Sales by Region (2021-2026) & (US$ Million) Table 44. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Region (2021-2026) Table 45. Global Vaccine Against Infectious Coryza for Poultry Sales (k doses), Value (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 46. Global Vaccine Against Infectious Coryza for Poultry Sales by Region (2027-2032) & (k doses) Table 47. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Region (2027-2032) Table 48. Global Vaccine Against Infectious Coryza for Poultry Sales by Region (2027-2032) & (US$ Million) Table 49. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Region (2027-2032) Table 50. Global Vaccine Against Infectious Coryza for Poultry Sales (k doses), Value (US$ Million), Price (US$/k dose) and Gross Margin (2027-2032) Table 51. Global Vaccine Against Infectious Coryza for Poultry Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2026) & (k doses) Table 53. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Application (2021-2026) Table 54. Global Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2026) & (US$ Million) Table 55. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Application (2021-2026) Table 56. Global Vaccine Against Infectious Coryza for Poultry Price by Application (2021-2026) & (US$/k dose) Table 57. Global Vaccine Against Infectious Coryza for Poultry Sales by Application (2027-2032) & (k doses) Table 58. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Application (2027-2032) Table 59. Global Vaccine Against Infectious Coryza for Poultry Sales by Application (2027-2032) & (US$ Million) Table 60. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Application (2027-2032) Table 61. Global Vaccine Against Infectious Coryza for Poultry Price by Application (2027-2032) & (US$/k dose) Table 62. North America Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2026) & (k doses) Table 63. North America Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2026) & (k doses) Table 65. Europe Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2026) & (k doses) Table 67. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2026) & (k doses) Table 69. Latin America Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2026) & (k doses) Table 71. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2026) & (US$ Million) Table 72. HIPRA Company Information Table 73. HIPRA Business Overview Table 74. HIPRA Vaccine Against Infectious Coryza for Poultry Sales (k doses), Revenue (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 75. HIPRA Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 76. HIPRA Recent Development Table 77. MSD Animal Health Company Information Table 78. MSD Animal Health Business Overview Table 79. MSD Animal Health Vaccine Against Infectious Coryza for Poultry Sales (k doses), Revenue (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 80. MSD Animal Health Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 81. MSD Animal Health Recent Development Table 82. Qilu Animal Health Company Information Table 83. Qilu Animal Health Business Overview Table 84. Qilu Animal Health Vaccine Against Infectious Coryza for Poultry Sales (k doses), Revenue (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 85. Qilu Animal Health Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 86. Qilu Animal Health Recent Development Table 87. Ringpu Company Information Table 88. Ringpu Business Overview Table 89. Ringpu Vaccine Against Infectious Coryza for Poultry Sales (k doses), Revenue (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 90. Ringpu Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 91. Ringpu Recent Development Table 92. Shandong Huahong Biological Company Information Table 93. Shandong Huahong Biological Business Overview Table 94. Shandong Huahong Biological Vaccine Against Infectious Coryza for Poultry Sales (k doses), Revenue (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 95. Shandong Huahong Biological Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 96. Shandong Huahong Biological Recent Development Table 97. Shandong Lvdu Bio-Sciences Company Information Table 98. Shandong Lvdu Bio-Sciences Business Overview Table 99. Shandong Lvdu Bio-Sciences Vaccine Against Infectious Coryza for Poultry Sales (k doses), Revenue (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 100. Shandong Lvdu Bio-Sciences Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 101. Shandong Lvdu Bio-Sciences Recent Development Table 102. Wohua Biotech Company Information Table 103. Wohua Biotech Business Overview Table 104. Wohua Biotech Vaccine Against Infectious Coryza for Poultry Sales (k doses), Revenue (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 105. Wohua Biotech Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 106. Wohua Biotech Recent Development Table 107. Jilin Zhengye Biological Products Company Information Table 108. Jilin Zhengye Biological Products Business Overview Table 109. Jilin Zhengye Biological Products Vaccine Against Infectious Coryza for Poultry Sales (k doses), Revenue (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 110. Jilin Zhengye Biological Products Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 111. Jilin Zhengye Biological Products Recent Development Table 112. North America Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 113. North America Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026) & (k doses) Table 114. North America Vaccine Against Infectious Coryza for Poultry Sales Market Share by Country (2021-2026) Table 115. North America Vaccine Against Infectious Coryza for Poultry Sales Forecast by Country (2027-2032) & (k doses) Table 116. North America Vaccine Against Infectious Coryza for Poultry Sales Market Share Forecast by Country (2027-2032) Table 117. North America Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Vaccine Against Infectious Coryza for Poultry Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Vaccine Against Infectious Coryza for Poultry Market Share by Country (2021-2026) Table 120. North America Vaccine Against Infectious Coryza for Poultry Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Vaccine Against Infectious Coryza for Poultry Market Share Forecast by Country (2027-2032) Table 122. Europe Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 123. Europe Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026) & (k doses) Table 124. Europe Vaccine Against Infectious Coryza for Poultry Sales Market Share by Country (2021-2026) Table 125. Europe Vaccine Against Infectious Coryza for Poultry Sales Forecast by Country (2027-2032) & (k doses) Table 126. Europe Vaccine Against Infectious Coryza for Poultry Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Vaccine Against Infectious Coryza for Poultry Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Vaccine Against Infectious Coryza for Poultry Market Share by Country (2021-2026) Table 130. Europe Vaccine Against Infectious Coryza for Poultry Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Vaccine Against Infectious Coryza for Poultry Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026) & (k doses) Table 134. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Forecast by Country (2027-2032) & (k doses) Table 136. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Market Share by Country (2021-2026) Table 140. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Market Share Forecast by Country (2027-2032) Table 142. Latin America Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 143. Latin America Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026) & (k doses) Table 144. Latin America Vaccine Against Infectious Coryza for Poultry Sales Market Share by Country (2021-2026) Table 145. Latin America Vaccine Against Infectious Coryza for Poultry Sales Forecast by Country (2027-2032) & (k doses) Table 146. Latin America Vaccine Against Infectious Coryza for Poultry Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Vaccine Against Infectious Coryza for Poultry Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Vaccine Against Infectious Coryza for Poultry Market Share by Country (2021-2026) Table 150. Latin America Vaccine Against Infectious Coryza for Poultry Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Vaccine Against Infectious Coryza for Poultry Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026) & (k doses) Table 154. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Forecast by Country (2027-2032) & (k doses) Table 156. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Market Share by Country (2021-2026) Table 160. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Vaccine Against Infectious Coryza for Poultry Distributors List Table 165. Vaccine Against Infectious Coryza for Poultry Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Vaccine Against Infectious Coryza for Poultry Image Figure 2. Global Vaccine Against Infectious Coryza for Poultry Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccine Against Infectious Coryza for Poultry Market Size (2021-2032) & (US$ Million) Figure 4. Global Vaccine Against Infectious Coryza for Poultry Sales (2021-2032) & (k doses) Figure 5. Serotype A Image Figure 6. Global Serotype A Sales YoY Growth (2021-2032) & (k doses) Figure 7. Serotype A + Serotype B Image Figure 8. Global Serotype A + Serotype B Sales YoY Growth (2021-2032) & (k doses) Figure 9. Serotype A + Serotype B + Serotype C Image Figure 10. Global Serotype A + Serotype B + Serotype C Sales YoY Growth (2021-2032) & (k doses) Figure 11. Global Vaccine Against Infectious Coryza for Poultry Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Vaccine Against Infectious Coryza for Poultry Market Share by Type 2025 VS 2032 Figure 13. North America Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Type in 2025 Figure 14. North America Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Type in 2025 Figure 15. Europe Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Type in 2025 Figure 16. Europe Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Type in 2025 Figure 19. Latin America Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Vaccine Against Infectious Coryza for Poultry Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Government Tender Image Figure 26. Global Government Tender Sales YoY Growth (2021-2032) & (k doses) Figure 27. Market Sales Image Figure 28. Global Market Sales Sales YoY Growth (2021-2032) & (k doses) Figure 29. Global Vaccine Against Infectious Coryza for Poultry Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Vaccine Against Infectious Coryza for Poultry Market Share by Application 2025 VS 2032 Figure 31. North America Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Application in 2025 Figure 32. North America Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Application in 2025 Figure 33. Europe Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Application in 2025 Figure 34. Europe Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Application in 2025 Figure 37. Latin America Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Market Share in Value by Application in 2025 Figure 41. North America Vaccine Against Infectious Coryza for Poultry Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 42. North America Vaccine Against Infectious Coryza for Poultry Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Vaccine Against Infectious Coryza for Poultry Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Vaccine Against Infectious Coryza for Poultry Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Vaccine Against Infectious Coryza for Poultry Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 46. Europe Vaccine Against Infectious Coryza for Poultry Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Vaccine Against Infectious Coryza for Poultry Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Vaccine Against Infectious Coryza for Poultry Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 50. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Vaccine Against Infectious Coryza for Poultry Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 54. Latin America Vaccine Against Infectious Coryza for Poultry Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Vaccine Against Infectious Coryza for Poultry Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Vaccine Against Infectious Coryza for Poultry Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 58. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Vaccine Against Infectious Coryza for Poultry Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Vaccine Against Infectious Coryza for Poultry Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Vaccine Against Infectious Coryza for Poultry Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Serotype A
  • Serotype A + Serotype B
  • Serotype A + Serotype B + Serotype C
Applications
  • Government Tender
  • Market Sales
Companies covered
  • HIPRA
  • MSD Animal Health
  • Qilu Animal Health
  • Ringpu
  • Shandong Huahong Biological
  • Shandong Lvdu Bio-Sciences
  • Wohua Biotech
  • Jilin Zhengye Biological Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vaccine Against Infectious Coryza for Poultry Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Vaccine Against Infectious Coryza for Poultry Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Vaccine Against Infectious Coryza for Poultry Market by Type
  6. 1.3.1 Serotype A
  7. 1.3.2 Serotype A + Serotype B
  8. 1.3.3 Serotype A + Serotype B + Serotype C
  9. 1.4 Global Vaccine Against Infectious Coryza for Poultry Market Size by Type
  10. 1.4.1 Global Vaccine Against Infectious Coryza for Poultry Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Vaccine Against Infectious Coryza for Poultry Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Vaccine Against Infectious Coryza for Poultry Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Vaccine Against Infectious Coryza for Poultry Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Vaccine Against Infectious Coryza for Poultry Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Vaccine Against Infectious Coryza for Poultry Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Vaccine Against Infectious Coryza for Poultry Industry Trends
  2. 2.2 Vaccine Against Infectious Coryza for Poultry Industry Drivers
  3. 2.3 Vaccine Against Infectious Coryza for Poultry Industry Opportunities and Challenges
  4. 2.4 Vaccine Against Infectious Coryza for Poultry Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Vaccine Against Infectious Coryza for Poultry Revenue (2021-2026)
  2. 3.2 Global Top Players by Vaccine Against Infectious Coryza for Poultry Sales (2021-2026)
  3. 3.3 Global Top Players by Vaccine Against Infectious Coryza for Poultry Price (2021-2026)
  4. 3.4 Global Vaccine Against Infectious Coryza for Poultry Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vaccine Against Infectious Coryza for Poultry Major Company Production Sites & Headquarters
  6. 3.6 Global Vaccine Against Infectious Coryza for Poultry Company, Product Type & Application
  7. 3.7 Global Vaccine Against Infectious Coryza for Poultry Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vaccine Against Infectious Coryza for Poultry Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vaccine Against Infectious Coryza for Poultry Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vaccine Against Infectious Coryza for Poultry Tier 1, Tier 2, and Tier 3
4 Vaccine Against Infectious Coryza for Poultry Regional Status and Outlook
  1. 4.1 Global Vaccine Against Infectious Coryza for Poultry Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Vaccine Against Infectious Coryza for Poultry Historic Market Size by Region
  3. 4.2.1 Global Vaccine Against Infectious Coryza for Poultry Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Vaccine Against Infectious Coryza for Poultry Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Vaccine Against Infectious Coryza for Poultry Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Vaccine Against Infectious Coryza for Poultry Forecasted Market Size by Region
  7. 4.3.1 Global Vaccine Against Infectious Coryza for Poultry Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Vaccine Against Infectious Coryza for Poultry Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Vaccine Against Infectious Coryza for Poultry Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vaccine Against Infectious Coryza for Poultry by Application
  1. 5.1 Vaccine Against Infectious Coryza for Poultry Market by Application
  2. 5.1.1 Government Tender
  3. 5.1.2 Market Sales
  4. 5.2 Global Vaccine Against Infectious Coryza for Poultry Market Size by Application
  5. 5.2.1 Global Vaccine Against Infectious Coryza for Poultry Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Vaccine Against Infectious Coryza for Poultry Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Vaccine Against Infectious Coryza for Poultry Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Vaccine Against Infectious Coryza for Poultry Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Vaccine Against Infectious Coryza for Poultry Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Vaccine Against Infectious Coryza for Poultry Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 HIPRA
  2. 6.1.1 HIPRA Company Information
  3. 6.1.2 HIPRA Business Overview
  4. 6.1.3 HIPRA Vaccine Against Infectious Coryza for Poultry Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 HIPRA Vaccine Against Infectious Coryza for Poultry Product Portfolio
  6. 6.1.5 HIPRA Recent Developments
  7. 6.2 MSD Animal Health
  8. 6.2.1 MSD Animal Health Company Information
  9. 6.2.2 MSD Animal Health Business Overview
  10. 6.2.3 MSD Animal Health Vaccine Against Infectious Coryza for Poultry Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 MSD Animal Health Vaccine Against Infectious Coryza for Poultry Product Portfolio
  12. 6.2.5 MSD Animal Health Recent Developments
  13. 6.3 Qilu Animal Health
  14. 6.3.1 Qilu Animal Health Company Information
  15. 6.3.2 Qilu Animal Health Business Overview
  16. 6.3.3 Qilu Animal Health Vaccine Against Infectious Coryza for Poultry Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qilu Animal Health Vaccine Against Infectious Coryza for Poultry Product Portfolio
  18. 6.3.5 Qilu Animal Health Recent Developments
  19. 6.4 Ringpu
  20. 6.4.1 Ringpu Company Information
  21. 6.4.2 Ringpu Business Overview
  22. 6.4.3 Ringpu Vaccine Against Infectious Coryza for Poultry Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ringpu Vaccine Against Infectious Coryza for Poultry Product Portfolio
  24. 6.4.5 Ringpu Recent Developments
  25. 6.5 Shandong Huahong Biological
  26. 6.5.1 Shandong Huahong Biological Company Information
  27. 6.5.2 Shandong Huahong Biological Business Overview
  28. 6.5.3 Shandong Huahong Biological Vaccine Against Infectious Coryza for Poultry Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shandong Huahong Biological Vaccine Against Infectious Coryza for Poultry Product Portfolio
  30. 6.5.5 Shandong Huahong Biological Recent Developments
  31. 6.6 Shandong Lvdu Bio-Sciences
  32. 6.6.1 Shandong Lvdu Bio-Sciences Company Information
  33. 6.6.2 Shandong Lvdu Bio-Sciences Business Overview
  34. 6.6.3 Shandong Lvdu Bio-Sciences Vaccine Against Infectious Coryza for Poultry Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shandong Lvdu Bio-Sciences Vaccine Against Infectious Coryza for Poultry Product Portfolio
  36. 6.6.5 Shandong Lvdu Bio-Sciences Recent Developments
  37. 6.7 Wohua Biotech
  38. 6.7.1 Wohua Biotech Company Information
  39. 6.7.2 Wohua Biotech Business Overview
  40. 6.7.3 Wohua Biotech Vaccine Against Infectious Coryza for Poultry Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Wohua Biotech Vaccine Against Infectious Coryza for Poultry Product Portfolio
  42. 6.7.5 Wohua Biotech Recent Developments
  43. 6.8 Jilin Zhengye Biological Products
  44. 6.8.1 Jilin Zhengye Biological Products Company Information
  45. 6.8.2 Jilin Zhengye Biological Products Business Overview
  46. 6.8.3 Jilin Zhengye Biological Products Vaccine Against Infectious Coryza for Poultry Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jilin Zhengye Biological Products Vaccine Against Infectious Coryza for Poultry Product Portfolio
  48. 6.8.5 Jilin Zhengye Biological Products Recent Developments
7 North America by Country
  1. 7.1 North America Vaccine Against Infectious Coryza for Poultry Sales by Country
  2. 7.1.1 North America Vaccine Against Infectious Coryza for Poultry Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026)
  4. 7.1.3 North America Vaccine Against Infectious Coryza for Poultry Sales Forecast by Country (2027-2032)
  5. 7.2 North America Vaccine Against Infectious Coryza for Poultry Market Size by Country
  6. 7.2.1 North America Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Vaccine Against Infectious Coryza for Poultry Market Size by Country (2021-2026)
  8. 7.2.3 North America Vaccine Against Infectious Coryza for Poultry Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Vaccine Against Infectious Coryza for Poultry Sales by Country
  2. 8.1.1 Europe Vaccine Against Infectious Coryza for Poultry Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026)
  4. 8.1.3 Europe Vaccine Against Infectious Coryza for Poultry Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Vaccine Against Infectious Coryza for Poultry Market Size by Country
  6. 8.2.1 Europe Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Vaccine Against Infectious Coryza for Poultry Market Size by Country (2021-2026)
  8. 8.2.3 Europe Vaccine Against Infectious Coryza for Poultry Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales by Country
  2. 9.1.1 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Market Size by Country
  6. 9.2.1 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Vaccine Against Infectious Coryza for Poultry Sales by Country
  2. 10.1.1 South America Vaccine Against Infectious Coryza for Poultry Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026)
  4. 10.1.3 South America Vaccine Against Infectious Coryza for Poultry Sales Forecast by Country (2027-2032)
  5. 10.2 South America Vaccine Against Infectious Coryza for Poultry Market Size by Country
  6. 10.2.1 South America Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Vaccine Against Infectious Coryza for Poultry Market Size by Country (2021-2026)
  8. 10.2.3 South America Vaccine Against Infectious Coryza for Poultry Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales by Country
  2. 11.1.1 Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Vaccine Against Infectious Coryza for Poultry Market Size by Country
  6. 11.2.1 Middle East and Africa Vaccine Against Infectious Coryza for Poultry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Vaccine Against Infectious Coryza for Poultry Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Vaccine Against Infectious Coryza for Poultry Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Vaccine Against Infectious Coryza for Poultry Value Chain Analysis
  2. 12.1.1 Vaccine Against Infectious Coryza for Poultry Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Vaccine Against Infectious Coryza for Poultry Production Mode & Process
  7. 12.2 Vaccine Against Infectious Coryza for Poultry Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Vaccine Against Infectious Coryza for Poultry Distributors
  10. 12.2.3 Vaccine Against Infectious Coryza for Poultry Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst